Symbol | Exchange | Currency |
|---|
ABUJA, Nov 25 (Reuters) - Nigerian stocks climbed to aone-week high on Wednesday after the central bank expressedoptimism that it expected a recession in Africa's biggesteconomy to...
Oct 30 (Reuters) - May & Baker Nigeria PLC MAYBAKE.LG : * MAY & BAKER NIGERIA PLC - QTRLY GROUP REVENUE FROMCONTINUINGOPERATIONS 2.37 BILLION NAIRA VERSUS 1.86 BILLION NAIRA...
Feb 14 (Reuters) - May & Baker Nigeria PLC MAYBAKE.LG :* QTRLY GROUP REVENUE FROM CONTINUING OPERATIONS 2.17BILLIONNAIRA VERSUS 2 BILLION NAIRA* QTRLY GROUP PBT 228.4 MILLION...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Sell | Buy | Buy | Strong Buy |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Buy | Strong Buy |
| Summary | Sell | Strong Sell | Neutral | Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.64 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 8.10 | 8.10 | 8.10 | -0.80 | -8.99% | 30.18K | Lagos | |||
| 0.45 | 0.00 | 0.00 | -0.04 | -8.16% | 1.33M | Lagos | |||
| 4.99 | 5.00 | 4.90 | +0.190 | +3.95% | 1.12M | Lagos | |||
| 3.08 | 3.08 | 3.08 | +0.08 | +2.67% | 8.25K | Lagos | |||
| 1.25 | 1.28 | 1.25 | +0.07 | +5.93% | 3.43M | Lagos | |||
| 0.68 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 0.25 | 0.00 | 0.00 | +0.01 | +4.17% | 3.03M | Lagos | |||
| 0.60 | 0.00 | 0.00 | -0.04 | -6.25% | 317.90K | Lagos | |||
| 1.54 | 1.54 | 1.54 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 55.90 | 55.90 | 55.90 | +2.95 | +5.57% | 10.14K | Lagos | |||
| 4.50 | 4.50 | 4.50 | -0.200 | -4.26% | 116.92K | Lagos | |||
| 1.19 | 1.19 | 1.19 | -0.110 | -8.46% | 35.70K | Lagos | |||
| 14.75 | 14.75 | 14.75 | -0.25 | -1.67% | 709.66K | Lagos | |||
| 5.78 | 5.78 | 5.78 | -0.570 | -8.98% | 130.08K | Lagos |
May & Baker Nigeria Plc manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria. It operates through Pharmaceuticals and Beverage segments. The company offers pharmaceuticals, including anti-diabetic; anti-hypersensitive; anti-infective; anti-malaria; analgesic; cough and cold; anxiolytics; and nature care products. It also provides beverage drinks, including bottled water; and hand and surface sanitizers. In addition, the company engages in contract manufacturing of pharmaceutical products; and sales, marketing, and distribution of medical devices, healthcare products, consumables, equipment and services, and personal care products. May & Baker Nigeria Plc was incorporated in 1944 and is headquartered in Lagos, Nigeria.